OCCL Ltd
OCCL Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q3 FY26 call signalled
0 of 2 strong
The short version
Volumes have been stable recently with no significant increase expected in the next quarter. Volumes have been stable with no significant increase expected in the next quarter; capacity utilization is around 70% with some increase anticipated in FY'27, but details will be clearer by May-June 2026.
From OCCL Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Volumes have been stable recently with no significant increase expected in the next quarter.
- Capacity utilization is currently around 70%, with some expected increase in FY'27, though exact levels will be clearer by May-June 2026.
- The company prioritizes capturing market share in exports despite global oversupply and weak international pricing.
- Domestic market share growth is a strategic focus, leveraging anti-dumping duties and favorable market conditions.
- Export market strategy, especially in the US and Europe, is expected to regain momentum following tariff reductions and discount normalization.
2 more points management made on revenue & sales performance
Profitability & Margins
See what OCCL Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what OCCL Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
OCCL Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹149 Cr, net profit ₹19 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What OCCL Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Balaji Amines Ltd (Q3 FY26)
Revenue from Operations for Q3FY26: ₹331.30 crore, compared to ₹320.59 crore in Q3FY25 (consolidated) and ₹304.68 crore in Q3FY25 (standalone). Key concall…
- Vidhi Specialty Food Ingredients Ltd (Q3 FY26)
94.5 Cr, down 4.1% YoY from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
- Bodal Chemicals Ltd (Q3 FY26)
5,046.6 Mn, up 13.3% YoY (Q3 FY25: Rs. Key concall takeaways from Bodal Chemicals Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
- Chemcon Speciality Chemicals Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations:** ₹57.3 Cr (vs ₹54.4 Cr in Q3 FY25) — approx. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q3 FY26 earnings…
Frequently Asked Questions
What were OCCL Ltd Q3 FY26 results?
Volumes have been stable recently with no significant increase expected in the next quarter. Volumes have been stable with no significant increase expected in the next quarter; capacity utilization is around 70% with some increase anticipated in FY'27, but details will be clearer by May-June 2026.
What is OCCL Ltd share price analysis?
OCCL Ltd currently shows a neutral. The stock trades at a P/E of 11.2 with a market cap of ₹855 Cr. Investors should review the full earnings analysis for detailed insights.
Is OCCL Ltd planning capital expenditure?
The transcript does not explicitly mention any current or planned capex, capital investment, or strategic investment by OCCL Limited.
Keep OCCL Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.